Table 1.
Clinical characteristics and ECMO outcomes for critically ill COVID-19 patients (N = 12)
| Variables | Mean (SD) | Range | n | % |
|---|---|---|---|---|
| Age (years) | 50.9 (13.5) | 35–76 | ||
| Gender (male) | 11 | 91.7 | ||
| Comorbidities | ||||
| Hypertension | 1 | 8.3 | ||
| Heart disease | 1 | 8.3 | ||
| Diabetes | 1 | 8.3 | ||
| Hyperthyroidism | 1 | 8.3 | ||
| Key reason for ICU admittance | ||||
| Dyspnea | 11 | 91.7 | ||
| Fever | 10 | 83.3 | ||
| Coma | 1 | 8.3 | ||
| Treatment type | ||||
| ECMO | 12 | 100 | ||
| Mechanical ventilation | 12 | 100 | ||
| Antibiotic treatment | 12 | 100 | ||
| Antiviral therapy | 12 | 100 | ||
| Glucocorticoid therapy | 10 | 83.3 | ||
| Supportive therapy based on symptoms | 12 | 100 | ||
| Duration of ECMO use (days) | 11.3 (7.8) | 3–28 | ||
| ECMO prognosis | ||||
| Improving without ECMO | 3 | 25.0 | ||
| Still alive with ECMO but two with coma | 4 | 33.3 | ||
| Dying | 5 | 41.7 | ||
Abbreviations: ECMO extracorporeal membrane oxygenation, ICU intensive care unit